1-8 of 8
João Raposo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cumulative Organ Dysfunction and Functional Status before and after Intensive Care Unit Admission Are Strong Predictors of Mortality in Patients with Hematologic Malignancies

Ana Vagos Mata, Daniel Gomes, Pedro Mendonça, Pedro De Vasconcelos, Daniela Alves, João Santos Silva, João Ribeiro, João F Lacerda, João Raposo
Journal: Blood
Blood (2022) 140 (Supplement 1): 8050–8051.
https://doi.org/10.1182/blood-2022-170720
Published: 2022
Journal Articles

Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease

Maria VD Soares, Virginia Escamilla Gomez, Rita I Azevedo, Paulo N.G. Pereira, Teresa Caballero Velázquez, Clara B. Garcia-Calderón, Kukatharmini Tharmaratnam, Inês A Cabral, Ana C Ribeiro, Laura Mendes, Clara Juncal, Susana Roncon, Ana Teresa Pais, Ana C Alho, Alfonso Rodriguez Gil, Eduardo L Espada, Anabela Rodrigues, Ana Garção, Marie-Laure Yaspo, Hans-Jörg Warnatz, Hans Lehrach, Nuno L. Barbosa-Morais, Ana Miguel Quintas, Paulo Palmela, Cecilia Caldas, Rosa Ferreira, Luis Leite, Carlos Martins, Fernanda Lourenço, Raúl Moreno, João Raposo, Fernando Campilho, Christopher Paul Cheyne, Marta Garcia-Fiñana, António Campos, Frédéric Baron, Mario Arpinati, Matthias Edinger, Jerome Ritz, Carlos Pinho Vaz, Jose A. Perez-Simon, Joao F Lacerda
Journal: Blood
Blood (2022) 140 (Supplement 1): 880–882.
https://doi.org/10.1182/blood-2022-163394
Published: 2022
Journal Articles

Disseminated Intravascular Coagulation Score Evolution in 48 Hours Predicts Early Death in Newly-Diagnosed Chemotherapy-Treated Acute Promyelocytic Leukemia Patients

Joana Brioso Infante, MD MSc, Graca Esteves, MD, Helena Martins, MD, Julia Medeiros, MD, Daniela Alves, MD, Conceicao Lopes, MD, Maria Joao Costa, MD, Maria Blanca Guerrero, MD, Raul Moreno, MD, Fernanda Lourenço, MD, Carlos Martins, MD, Joao F Lacerda, MD PhD, João Raposo, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-143138
Published: 2020
Journal Articles

Safety of Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Results from the Primary Analysis of the Phase 3b GREEN Study

Stephan Stilgenbauer, MD PhD, Melih Aktan, Christelle M Ferra Coll, Caroline Dartigeas, Jens Kisro, Marco Montillo, MD, João Raposo, Jean-Louis Merot, Susan Robson, Ekaterina Gresko, Francesc Bosch, Robin Foà, MD, Véronique Leblond
Journal: Blood
Blood (2017) 130 (Supplement 1): 4309.
https://doi.org/10.1182/blood.V130.Suppl_1.4309.4309
Published: 2017
Journal Articles

Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL

Clinical Trials & Observations
Fritz Offner, Olga Samoilova, Evgenii Osmanov, Hyeon-Seok Eom, Max S. Topp, João Raposo, Viacheslav Pavlov, Deborah Ricci, Shalini Chaturvedi, Eugene Zhu, Helgi van de Velde, Christopher Enny, Aleksandra Rizo, Burhan Ferhanoglu
Journal: Blood
Blood (2015) 126 (16): 1893–1901.
https://doi.org/10.1182/blood-2015-03-632430
Published: 2015
Includes: Supplemental data
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) Eligible For High Dose Melphalan (HDM)

Graça Esteves, MD, Manuel L Neves, Helena Martins, Carlos M. Martins, MD, Maria Joao Costa, MD, Sara Valle, MD, Conceição Lopes, MD, João Raposo, MD, Lurdes Guerra, MD, Blanca Polo, MD, Ana Alho, Carolina Viveiros, MD, Susana Mendes, Rita Ferreira, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 1873.
https://doi.org/10.1182/blood.V122.21.1873.1873
Published: 2013
Journal Articles

Serum Free Light Chain Ratio (FLCr) Is a Powerful Prognostic Factor For Survival In Newly Diagnosed Multiple Myeloma (MM) In The Era Of New Agents Namely On ISS Stage II Patients

Graça V Esteves, MD, Manuel L Neves, Helena F Martins, Maria Joao Costa, MD, Sara Valle, MD, João Raposo, MD, Carlos M. Martins, MD, Lurdes Guerra, MD, Conceição Lopes, MD, Susana Mendes, Ana Alho, Rita Ferreira, Carolina Viveiros, MD, Eduardo Espada, Inês Conde, Daniela Alves, Joao F Lacerda, MD, PhD, Blanca Polo, MD, Helena Proença, MD, José A Carmo, MD
Journal: Blood
Blood (2013) 122 (21): 3150.
https://doi.org/10.1182/blood.V122.21.3150.3150
Published: 2013
Journal Articles

Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).

Veronique Leblond, Kamel Laribi, MD, Osman Ilhan, MD, Melih Aktan, Ali Unal, MD, Saad M B Rassam, MD, FRCP, FRCPath, Anna Schuh, MD, PhD, MRCP, FRCPath, Tom Widenius, MD, PhD, Peter Johansson, MD, PhD, Joao Raposo, Balkis Meddeb, Carol Moreno, MD, PhD, Stephan H.K. Oertel, MD, Anne-Sophie Michallet, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2744.
https://doi.org/10.1182/blood.V120.21.2744.2744
Published: 2012